🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10530+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 10530 recruiting trials

Phase 2RecruitingNCT06914674

Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas

👨‍⚕️ Guopei Luo Prof, MD, Shanghai Cancer Center📍 1 site📅 Started Mar 2025View details ↗
Phase 3RecruitingNCT06842823

A Study of Navenibart in Participants With Hereditary Angioedema

🏥 Astria Therapeutics, Inc.📍 79 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06708949

A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)

👨‍⚕️ Eric Jonasch, MD, M.D. Anderson Cancer Center📍 5 sites📅 Started Mar 2025View details ↗
NARecruitingNCT06894901

Impact of IIT-SIT on Dengue Clusters

👨‍⚕️ Lee Ching Ng Group Director (Environmental Health Institute), PhD, Environmental Health Institute📍 1 site📅 Started Mar 2025View details ↗
EARLY_Phase 1RecruitingNCT06891703

[18F]ACI-15916 PET in α-synucleinopathies

👨‍⚕️ Andrea Varrone, Prof., Karolinska Institutet📍 1 site📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06604520

Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia

👨‍⚕️ Christopher Morrow, MD, Johns Hopkins University📍 1 site📅 Started Mar 2025View details ↗
RecruitingNCT06270771

OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study

🏥 Sunnybrook Health Sciences Centre📍 1 site📅 Started Mar 2025View details ↗
Phase 1RecruitingNCT06692426

Trial of Cell Based Therapy for DMD

👨‍⚕️ Peter Kang, MD📍 1 site📅 Started Mar 2025View details ↗
Phase 3RecruitingNCT06925594

Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease

🏥 Jiangsu Topcel-KH Pharmaceutical Co., Ltd.📍 1 site📅 Started Mar 2025View details ↗
Phase 4RecruitingNCT06806657

Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab

👨‍⚕️ Study Director, CSL Behring📍 10 sites📅 Started Mar 2025View details ↗
RecruitingNCT06881004

Biliary Dilatation National Special Disease Cohort in China

👨‍⚕️ Shuo Jin, PhD, Beijing Tsinghua Chang Gung Hospital📍 1 site📅 Started Mar 2025View details ↗
NARecruitingNCT05527093

Cartography of Social Cognition Network and Their Alterations in Patients With Epilepsy

🏥 Assistance Publique - Hôpitaux de Paris📍 2 sites📅 Started Mar 2025View details ↗
Phase 1RecruitingNCT06830031

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

👨‍⚕️ Liang Huang, MD, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences📍 1 site📅 Started Mar 2025View details ↗
Phase 4RecruitingNCT06857942

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

👨‍⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 43 sites📅 Started Mar 2025View details ↗
NARecruitingNCT06565169

Improving PCP Advance Care Planning for People With ADRD

👨‍⚕️ Christine E. Kistler, MD, MASc, University of Pittsburgh, Department of Medicine, Division of Geriatric Medicine📍 1 site📅 Started Mar 2025View details ↗
RecruitingNCT07334444

Optimizing the Management of OSA in Children With Down Syndrome

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started Mar 2025View details ↗
Phase 1, PHASE2RecruitingNCT06644183

Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)

👨‍⚕️ Jennifer Brown, MD, PhD, Dana-Farber Cancer Institute📍 1 site📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06942520

Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)

🏥 Sierra Eye Associates📍 1 site📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06853743

The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease

👨‍⚕️ Lasse Pihlstrøm, PhD, Oslo University Hospital📍 1 site📅 Started Mar 2025View details ↗
RecruitingNCT04252066

A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

🏥 Amicus Therapeutics📍 1 site📅 Started Mar 2025View details ↗
← PreviousPage 134 of 527Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →